2Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3 [J]. Science, 2003, 299(5609) : 1057-1061.
3Fontenot J D, Gavin M A, Rudensky A Y. Foxp3 program the development and function of CD4^+ CD25^+ regulatory T ceils [J]. Nat Immunol, 2003,4(4) :330-336.
4Walker M R, Kasprowicz D J, Gersuk V H, et al. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4^+CD25^- T cell [J]. J Clin Invest, 2003,112(9) : 1437-1443.
5Peng Y, Laouar Y, Li M O, et al, TGF-beta regulates in vivo expansion of Foxp3-expressing CD4^+ CD25^+ regulatory T cells responsible for protection against diabetes [J]. Proc Natl Acad Sci USA, 2004, 101 ( 13 ) : 4572-4577.
6Zhao D M,Thornton A M, Dipaolo R J, et al. Activated CD4^+CD25^+ T cells selectively kill B lymphocytes [J]. Blood, 2006,107 (10) : 3925-3932.
7Bennett C L, Christie J, Ramsdell F, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FoxP3 [J]. Nat Genet, 2001,27 (1):20-21.
8Gatti RA, Good RA. Occurrence of malignancy in immunodeficiency diseases. A literature review [J]. Cancer, 1971,28( 1 ) : 89-98.
9Hoshida Y, Tsuknma H, Yasunaga Y, et al. Cancer risk after renal transplantation in Japan [J]. Int J Cancer, 1997,71 (4) :517-520.
10Sakaguchi S, Sakaguchi N, Shimizu J, et al. Immunologic tolerance maintained by CD25" CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance [J]. Immunol Rev, 2001,182: 18-32.
